作者
Yang Zhao,Wanzhen Cui,Tingting Xie,Kai Zhao,Yunke Li,Yingfeng Wan,Xia Wang,Qiang Li,Xiaoying Chen,Zhenchuan Liu,Haining Zhao,Baoying Gong,Ruihua Wang,Manli Wu,Dou Wang,Yanwen Zheng,Yanjia Chen,Yue Chen,Qihua Guo,Changlian Gan,Fengyuan Che,Lili Song,Craig S. Anderson,Jianwen Guo
摘要
The popular traditional Chinese medicine (TCM) compound FYTF-919 (Zhong Feng Xing Nao prescription) may improve outcome from acute intracerebral hemorrhage (ICH) through effects on brain edema, hematoma absorption, and the immune system. This study is to assess whether FYTF-919 is safe and effective as compared to matching placebo treatment in patients with acute ICH.